The Global Human Milk Oligosaccharides (HMO) Market, valued at USD 100.8 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 16.4% during the forecast period from 2024 to 2030, reaching USD 250.1 million by 2030. The Human Milk Oligosaccharides (HMO) market is experiencing rapid growth, driven by increasing awareness of the critical health benefits these complex carbohydrates provide. HMOs, found naturally in human breast milk, play a vital role in infant health by promoting gut health, enhancing immune function, and offering protection against infections. With the rising demand for infant formula that closely replicates the benefits of human milk, HMOs are becoming an essential ingredient in the nutrition industry.

Technological advancements in biotechnology have facilitated the large-scale production of HMOs, making them accessible for a range of applications beyond infant nutrition. These include dietary supplements, functional foods and beverages, and potential uses in medical and personal care products. The market's expansion is further propelled by a growing focus on preventive healthcare and the increasing consumer preference for functional foods that support overall health and well-being.

Growth Drivers

Growing focus on preventive healthcare

The Human Milk Oligosaccharides (HMOs) market is experiencing a surge in demand driven by increasing awareness of their health benefits, particularly in infant nutrition and functional foods. HMOs are naturally occurring complex sugars found in breast milk, known for their ability to support infant health by promoting a healthy gut microbiome, aiding in immune system development, and potentially reducing the risk of infections and allergies.

In infant nutrition, HMOs are being recognized as valuable components that mimic the benefits of breast milk, leading to their inclusion in infant formulas and baby foods. Parents and healthcare professionals are increasingly seeking products containing HMOs to provide optimal nutrition for infants who are not exclusively breastfed.


Regulatory hurdles and stringent approval processes

Navigating regulatory hurdles and stringent approval processes presents a significant challenge in the Human Milk Oligosaccharides (HMOs) market. Due to the critical nature of products targeting infants and dietary supplements, regulatory bodies impose rigorous standards to ensure safety, efficacy, and quality. The complexity of HMOs as novel ingredients adds to the challenge, requiring extensive scientific data and clinical studies to support their use in food and nutritional products.

These regulatory hurdles can delay product development timelines, increase costs, and pose barriers to market entry for companies. Companies must invest in comprehensive research, toxicological assessments, and regulatory submissions, often involving multiple regulatory agencies across different regions.

Impact of Escalating Geopolitical Tensions on Global Human Milk Oligosaccharides Market

Escalating geopolitical tensions have a multifaceted impact on the global Human Milk Oligosaccharides (HMOs) market. These tensions can disrupt supply chains, leading to uncertainties in sourcing raw materials and manufacturing processes. International trade restrictions, tariffs, and sanctions imposed during geopolitical conflicts can also hinder the movement of HMO-based products across borders, affecting distribution networks and market access. Furthermore, geopolitical instability may influence consumer confidence and behavior, impacting demand for HMOs in different regions. Economic repercussions of geopolitical tensions, such as currency fluctuations and market volatility, can affect pricing strategies and overall market dynamics. Additionally, regulatory environments may be affected by geopolitical changes, with potential shifts in trade agreements, standards, and import/export regulations. This can create challenges for companies operating in the HMOs market, requiring them to adapt quickly to evolving regulatory landscapes. Moreover, geopolitical tensions can impact investment decisions, research collaborations, and strategic partnerships within the HMOs industry. Uncertainties related to geopolitical stability may lead to cautious approaches by stakeholders, affecting innovation, expansion plans, and market growth opportunities.

Global Human Milk Oligosaccharides Market

Segmental Coverage

Global Human Milk Oligosaccharides Market – By Product

Based on product type, 2'-Fucosyllactose segment is expected to grow in the forecast period as 2'-FL is one of the most abundant and well-studied HMOs naturally present in breast milk, making it highly desirable for infant nutrition and functional food applications. Its structural similarity to the oligosaccharides found in human milk gives it a strong biological relevance and potential health benefits. Secondly, research has highlighted the positive effects of 2'-FL on infant health, including its role in supporting a healthy gut microbiome, enhancing immune system development, and potentially reducing the risk of infections and allergies in infants. These documented health benefits have increased the demand for products containing 2'-FL, such as infant formulas, baby foods, and dietary supplements. Moreover, advancements in biotechnological processes have enabled the production of 2'-FL on a commercial scale, making it more accessible for incorporation into various consumer products. This availability, coupled with growing consumer awareness of HMOs and their benefits, has fueled the growth of the 2'-FL segment in the HMOs market. Additionally, regulatory approvals and endorsements from healthcare professionals further contribute to the prominence of 2'-FL, solidifying its position as a leading growth segment within the global HMOs market.

Global Human Milk Oligosaccharides Market – By End Use Application

The infant nutrition segment is anticipated to experience significant growth in the forecast period due to the natural abundance of Human Milk Oligosaccharides (HMOs) in human breast milk. HMOs play pivotal roles in infant health by fostering a healthy gut microbiome, bolstering immune system development, and facilitating the digestion and absorption of nutrients. As breast milk is considered the gold standard for infant nutrition, manufacturers strive to mimic its composition as closely as possible in infant formula, leading to the inclusion of HMOs. Furthermore, HMOs are believed to offer benefits that extend beyond basic nutrition, such as reducing the risk of infections, allergies, and inflammatory conditions in infants. This added health value drives parents and healthcare professionals to prefer infant formulas supplemented with HMOs, enhancing the market demand.

Furthermore, research and clinical studies continue to demonstrate the positive impact of HMOs on infant health outcomes, further bolstering their demand in infant formula. Regulatory approvals and endorsements from health authorities also contribute to the growing acceptance and adoption of HMO-enriched infant formulas, solidifying their position as a sought-after component in early childhood nutrition.

Global Human Milk Oligosaccharides Market – By Form

Based on Form, the Amorphous Powder is expected to grow in the forecast period owing to its superior solubility and bioavailability. Amorphous Powder has a non-crystalline structure, which makes it easier to dissolve in liquids, such as infant formula, beverages, or dietary supplements. This property enhances its usability and allows for better incorporation into various food and nutritional products without compromising on texture or taste.

Additionally, Amorphous Powder typically exhibits improved stability and shelf-life compared to Crystalline Powder, making it a preferred choice for manufacturers seeking long-term product stability and quality. The enhanced solubility and stability of Amorphous Powder contribute to its higher demand in the market, especially in applications where quick dissolution, effective delivery, and product longevity are essential factors influencing consumer satisfaction and product performance.

Contact Us:

BlueWeave Consulting & Research Pvt Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

Author's Bio: 

Blueweave Consulting offers a one-stop solution for your market intelligence needs for any service or product. You get well-researched comprehensive reports based on qualitative and quantitative data to put your business plan into action. Your well-informed and timely decisions using our reports avert situations of excessive risks and help you grow your business with optimum risk-return trade-off.